Vaccine Science & Options
Vaccines help eradicate many diseases throughout the world.
The production of vaccines involves growing a virus in living cells. Historically they have been manufactured by using animal cell lines that contain the Deoxyribonucleic Acid (DNA) of that animal. Within the final product some residual living DNA remains as a contaminant in the vaccine as it cannot all be filtered out. In 1979 changes were introduced to vaccine manufacturing previously made in animal cell lines to manufacturing in human fetal cell lines. Therefore with each dose of the vaccines newly manufactured on human cells we are injecting children and adults with residual human fetal DNA and in some cases a retrovirus.
It is a well understood scientific fact that lose, living human DNA in a human can insert into the genome of that human. As the DNA in the genes govern the function of cells, such DNA insertions can seriously disrupt the function of the invaded cell. If this loose DNA invades the genes governing the function of a nerve cell in the brain, such disruption can have devastating consequences. Therefore, SCPI researches the potential health risks of the residual human DNA found in the products we use.
Many scientists have now hypothesized that cancer and other childhood neurological diseases such as autistic disorder are caused by mutations in the child’s DNA. This conclusion is based upon finding numerous mutations in the brains and/or blood of such children which cannot be found in their parents, these are called de novo mutations. They are caused by something that happens to the child after birth. SCPI researches have extensively reviewed the potential health risks posed by this residual human DNA. Based upon that research, SCPI does ongoing research and seeks to raise awareness of the potential health risks of manufacturing medical products on human cell lines.